Budesonide–formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial

The Lancet Respiratory Medicine 2026

View at publisher
Authors: J Noble, Orlagh Bean, Melissa Perry, Ross Sayers, Ryan Cullen, Bianca Black, Mark Holliday, Allie Eathorne, Nick Shortt, Louis Kirton, Blake G. Perry, Pepa Bruce
+16 more William Leung, Ian Pavord, Mark Weatherall, R. C. Beasley, Augustus Anderson, Christina Eldar, Trisha Falleni, Matire Harwood, Kyley Kerse, Joseph Kulathinal, Francesca Lynch, John Martindale, Dianne Sika Paotonu, Ruth Semprini, Alex Semprini, Jenny Sparks
DOI: 10.1016/s2213-2600(25)00327-3
Cited by: 3
References: 29

Fields of Study & Subjects

Asthma and respiratory diseases Pharmacological Effects and Assays Inhalation and Respiratory Drug Delivery

Publication details

Journal / source
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Volume
14
Issue
2
Pages
151–162
Publication date
9 January 2026
Language
EN